Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Thiazolidinedione safety.

Kung J, Henry RR.

Expert Opin Drug Saf. 2012 Jul;11(4):565-79. doi: 10.1517/14740338.2012.691963. Epub 2012 May 22. Review.

PMID:
22616948
2.

[Steatosis and steatohepatitis in diabetic patient].

Hůlek P, Dresslerová I.

Vnitr Lek. 2011 Apr;57(4):364-7. Review. Czech.

PMID:
21612059
3.

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database.

Berthet S, Olivier P, Montastruc JL, Lapeyre-Mestre M.

BMC Clin Pharmacol. 2011 May 24;11:5. doi: 10.1186/1472-6904-11-5.

4.

Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.

Beiderbeck AB, Sakaguchi M.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1247-9. doi: 10.1002/pds.1872. No abstract available.

PMID:
19842093
5.

Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.

Osei SY, Koro CE, Cobitz AR, Kolatkar NS, Stender M.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1244-6. doi: 10.1002/pds.1840. No abstract available.

PMID:
19655316
6.

Case series of liver failure associated with rosiglitazone and pioglitazone.

Floyd JS, Barbehenn E, Lurie P, Wolfe SM.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1238-43. doi: 10.1002/pds.1804.

PMID:
19623674
7.

Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: effectiveness and side effects.

Chiang CK, Ho TI, Peng YS, Hsu SP, Pai MF, Yang SY, Hung KY, Wu KD.

Diabetes Care. 2007 Jan;30(1):3-7.

PMID:
17192324
8.

Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.

Strowig SM, Raskin P.

Diabetes Obes Metab. 2005 Nov;7(6):633-41. Review.

PMID:
16219007
9.

Hepatic injury in a patient taking rosiglitazone.

Menees SB, Anderson MA, Chensue SW, Moseley RH.

J Clin Gastroenterol. 2005 Aug;39(7):638-40.

PMID:
16000935
10.
11.

Second-generation thiazolidinediones and hepatotoxicity.

Marcy TR, Britton ML, Blevins SM.

Ann Pharmacother. 2004 Sep;38(9):1419-23. Epub 2004 Jul 20.

PMID:
15266041
12.

Hepatotoxicity of thiazolidinediones.

Isley WL.

Expert Opin Drug Saf. 2003 Nov;2(6):581-6. Review.

PMID:
14585066
13.

Thiazolidinediones in diabetes: current status and future outlook.

Camp HS.

Curr Opin Investig Drugs. 2003 Apr;4(4):406-11. Review.

PMID:
12808879
14.

[Meta-analysis shows: insulin sensitizer is safe for the liver].

[No authors listed]

MMW Fortschr Med. 2002 Oct 3;144(40):47. German. No abstract available.

PMID:
12440297
15.

[Severe electrolyte imbalance and edema in therapy with rosiglitazone].

Kuschel U, Hesselbarth N, Herrmann A, Hippius M, Hoffmann A.

Med Klin (Munich). 2002 Sep 15;97(9):553-5. German.

PMID:
12371084
16.

Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.

Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B.

Dig Dis Sci. 2002 Jul;47(7):1632-7.

PMID:
12141828
17.

Thiazolidinedione hepatotoxicity: a class effect?

Tolman KG.

Int J Clin Pract Suppl. 2000 Oct;(113):29-34. Review.

PMID:
11965828
18.

Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells.

Yamamoto Y, Nakajima M, Yamazaki H, Yokoi T.

Life Sci. 2001 Dec 14;70(4):471-82.

PMID:
11798015
19.

Hepatotoxicity with thiazolidinediones: is it a class effect?

Scheen AJ.

Drug Saf. 2001;24(12):873-88. Review.

PMID:
11735645
20.

Lessons from the glitazones: a story of drug development.

Gale EA.

Lancet. 2001 Jun 9;357(9271):1870-5. Review.

PMID:
11410214
Items per page

Supplemental Content

Loading ...
Write to the Help Desk